Intravenous arketamine for treatment-resistant depression: open-label pilot study
Gustavo C. Leal, Igor D. Bandeira, Fernanda S. Correia‐Melo, Manuela Telles, Rodrigo P. Mello, Flávia Vieira, Cassio Santos‐Lima, Ana Paula Jesus‐Nunes, Lívia N. F. Guerreiro‐Costa, Roberta Ferrari Marback, Ana Teresa Caliman‐Fontes, Breno Souza‐Marques, Marília Lopes Oliveira Bezerra, Alberto L. Dias-Neto, Samantha S. Silva, Aline S. Sampaio, Gerard Sanacora, Gustavo Turecki, Colleen Loo, Acioly L.T. Lacerda, Lucas C. Quarantini
Topics & Concepts
Treatment-resistant depressionAntidepressantKetamineDepression (economics)Rating scaleMedicineAnesthesiaPilot trialClinical trialPsychologyInternal medicineRandomized controlled trialHippocampusEconomicsMacroeconomicsDevelopmental psychologyTreatment of Major DepressionNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research